Enhanced thrombin generation in plasma of severe thrombocytopenic patients due to rFVIIa

被引:3
作者
Novak, M.
Hiden, M.
Rehak, T.
Rosenkranz, A.
Zebisch, A. [2 ]
Sill, H. [2 ]
Klaschka, S. [3 ]
Muntean, W. [1 ]
机构
[1] Med Univ Graz, Univ Klin Kinder & Jugendheilkunde, Dept Paediat, A-8036 Graz, Austria
[2] Med Univ Graz, Dept Internal Med, A-8036 Graz, Austria
[3] Med Univ Graz, Med Res Ctr, A-8036 Graz, Austria
来源
HAMOSTASEOLOGIE | 2008年 / 28卷
关键词
Thrombin generation; rFVIIa; thrombocytopenia; microparticles;
D O I
10.1055/s-0037-1621422
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
RFVIIa-enhanced thrombin generation has been shown to be dependent on platelets. In previous work we have shown that addition of monocytes and RFVIIa to microparticle free plasma causes a distinct thrombin generation. The aim of our study has been to examine whether there is enough surface provided by microparticles in thrombocytopenic plasma to allow an effect of RFVIIa. Patients, methods: Thrombin generation was measured in platelet rich plasma (PRP) and microparticle free plasma (MFP) of thrombocytopenic haemato-oncological patients with and without addition of rVIIa by means of calibrated automated thrombography. Microparticles were analyzed in PRP by FACS flow cytometry. Results: Microparticle free plasma showed no thrombin generation with or without addition of RFVIIa. Addition of RFVIIa to PRP of thrombocytopenic patients led to a significant shortening of lag time and time to peak in thrombin generation, while ETP and peak remained unchanged. Conclusion: Our results show that even in plasma of severe thrombocytopenic patients enough surface may be provided by microparticles to allow an enhancement of thrombin generation by RFVIIa.
引用
收藏
页码:S77 / S80
页数:4
相关论文
共 20 条
  • [1] Aitken Michael G, 2004, Emerg Med Australas, V16, P446, DOI 10.1111/j.1742-6723.2004.00648.x
  • [2] Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy
    Atkison, PR
    Jardine, L
    Williams, S
    Barr, RM
    Quan, D
    Wall, W
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1091 - 1093
  • [3] Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura
    Baxter, Melissa S.
    Schroeder, Walter S.
    Cheng, Yijun
    Bernstein, Zale P.
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (11) : 2053 - 2058
  • [4] How factor VIIa works in hemophilia
    Butenas, S
    Brummel, KE
    Bouchard, BA
    Mann, KG
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (06) : 1158 - 1160
  • [5] Increased local procoagulant action:: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders
    Galán, AM
    Tonda, R
    Pino, M
    Reverter, JC
    Ordinas, A
    Escolar, G
    [J]. TRANSFUSION, 2003, 43 (07) : 885 - 892
  • [6] Mechanism of action of factor VIIa in the treatment of coagulopathies
    Hedner, Ulla
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 : 77 - 85
  • [7] The Calibrated Automated Thrombogram (CAT):: A universal routine test for hyper- and hypocoagulability
    Hemker, HC
    Giesen, P
    AlDieri, R
    Regnault, V
    de Smed, E
    Wagenvoord, R
    Lecompte, T
    Béguin, S
    [J]. PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 (5-6) : 249 - 253
  • [8] A cell-based model of coagulation and the role of factor VIIa
    Hoffman, M
    [J]. BLOOD REVIEWS, 2003, 17 : S1 - S5
  • [9] Measuring circulating cell-derived microparticles
    Jy, W
    Horstman, LL
    Jimenez, JJ
    Ahn, YS
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (10) : 1842 - 1851
  • [10] Incorporating manufacturing tolerances in near-optimal design of composite structures
    Kristinsdottir, BP
    Zabinsky, ZB
    Tuttle, ME
    Csendes, T
    [J]. ENGINEERING OPTIMIZATION, 1996, 26 (01) : 1 - 23